Filing metadata

Accession number
0001683168-23-003077
Form type
Form 3
Filer
CNS Pharmaceuticals, Inc.
CIK
CIK 1729427
Filed
May 09, 2023
Reporting period
May 03, 2023
Description
Initial ownership

Explore SEC Filings Hub